Govt job for M.Pharm, M.Sc for Project Assistant at NIPER

National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad is an Institute of National Importance with proclaimed objectives of becoming Centre of Excellence for advanced research in pharmaceutical sciences.

NIPER-Mohali was the first institute established in the year 1998 under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the Govt. of India.

Post : Project Assistant

Applications are invited for a Project Assistant in Lateral Flow Immunoassay Development to work under the supervision of Dr. Vivek Borse for a period of 11 months.

The project involves synthesis, characterization of nanoparticles, bioconjugation and development of lateral flow immunoassay.

Qualifications : B.Sc./ 3 years Diploma in Engineering & Technology
Desirable – B.E., B.Tech, M.Sc., M.Pharm, M.Tech. with practical knowledge, expertise, specialization in Biotechnology, Microbiology, Pharmacy, Bioengineering, Medical Devices, NanoBioTechnology, etc.)

Upper age limit : 50 years

How to Apply
A detailed resume including applicant’s personal details with photograph, educational background, statement of purpose, name of two referees, and copy of all credentials should be submitted by email (vivek.borse@niperhyd.ac.in).

Incomplete application will not be considered.

Last date of receiving applications is 05th October, 2021

Interview date : Interviews will be held as soon as possible thereafter.
Note : Only shortlisted candidates will be intimated to appear for an interview (Online or Offline); No TA/DA will be paid for attending the same

Related Posts

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India